Tuesday Analyst Upgrades and Downgrades

 StocksRunner
 
  StocksRunner
 
Follow  Message
 
 
 
Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends
 

•  27 May 2025
 

$ALXO H.C. Wainwright maintaining its Buy rating. However, the market didn’t share the optimism, dragging the stock down nearly 5% on the day. For ALX Oncology investors, the reaffirmed Buy comes at a time when the stock's momentum appears to be stalling, raising questions about what catalyst could reignite interest.

$AMD received a confidence boost as part of a broad tech analyst upgrade wave that included names like $NVDA and $MSFT. Shares responded with a strong 3.85% rally, indicating traders are buying into the bullish sentiment—perhaps driven by the chip sector’s growing role in AI and data center growth.

$AZO delivered solid Q3 results, including a 5.4% bump in same-store sales and EPS north of $35, but the stock dropped more than 3.5%. Despite positive fundamentals, it looks like investors took profits or reacted to a broader downgrade, reminding us that even good news can get overshadowed when expectations are sky-high.

$BLFS kept its Buy rating from H.C. Wainwright, along with a $30 price target. The stock inched up over 2%, showing some early traction. BioLife's long-term appeal remains intact, but it may need stronger momentum or news flow to break higher.

$BWAY also retained its Buy status and $16 target, but the stock slid slightly. It’s a reminder that not every reaffirmed Buy equates to immediate upside, especially when volume stays light and market sentiment remains cautious.

$CMC was one of Tuesday biggest analyst-inspired winners. An upgrade helped push shares up over 6%, showing how sensitive this steel play is to sentiment shifts. Traders clearly liked what they heard from analysts who flipped their stance, perhaps seeing value in the industrial name amid infrastructure tailwinds.

$CMI got the nod from Goldman Sachs, which upgraded Cummins to Buy. The stock rallied nearly 3%, a solid move for a heavyweight name. Analysts pointed to its emerging data center role and evolving profit streams—an angle that could fuel more re-rating if traction builds.

$DOCU saw bullish coverage initiated with a Buy rating, citing upside from AI-driven agreements. Investors were on board, lifting shares nearly 2%. If AI adoption continues to deepen across enterprise software, DocuSign may quietly be carving out a second act.

$GRPN was met with a harsh downgrade to Strong Sell. Despite that, the stock rallied over 6%, highlighting either a short squeeze or traders betting against the bearish call. It’s volatile, and clearly not for the faint of heart.

$LFST surged more than 10% after UBS upgraded it based on valuation. That spike suggests Wall Street is beginning to notice this under-the-radar healthcare name. It’s still trading at modest levels, which could mean more room to run if sentiment shifts broadly.

$LPG was another name that caught attention thanks to an analyst upgrade. Shares were up nearly 3% as talk of a dividend hike added fuel to the move. With income potential and shipping demand looking healthy, it could remain on radar for yield hunters.

$LUV got a lift—literally—from Jefferies, which raised its rating after management meetings. The airline stock gained more than 5%, reflecting both the positive commentary and potentially improving operational sentiment in the sector.

$RIVN was upgraded, but analysts at UBS tempered expectations, setting a price target below its current level. Shares dipped a bit, suggesting investors are weighing near-term affordability concerns against long-term EV hype. The upcoming R2 launch will be a critical litmus test.

$SMWB jumped more than 2% after its upgrade, as analysts noted its cheaper valuation. That’s often the magic word for value-focused traders. Similarweb still has some proving to do, but today’s move might hint at a potential trend reversal.

$WOLF was initiated with a Buy, and the name bounced 3.5% as traders latched onto the idea that Wolfspeed isn’t dead yet. Whether this rally has legs depends on how well it can turn sentiment around in the high-risk chip space.

$WRBY had its Buy rating reiterated by Loop Capital, and shares were up nearly 4%. Warby Parker’s consumer-focused model may be winning quiet fans as discretionary retail holds steady despite broader economic headwinds.

$X found itself back in Wall Street’s favor with a fresh upgrade. The stock rose just over 1%, modest but directionally aligned with the bullish call. If steel prices stabilize or rise, $X could be well-positioned.